Skip to main content
. Author manuscript; available in PMC: 2020 Jul 6.
Published in final edited form as: Mol Pharm. 2019 Mar 11;16(4):1433–1443. doi: 10.1021/acs.molpharmaceut.8b00959

Figure 1. Verteporfin decreases proliferation and radiosensitizes glioblastoma cells.

Figure 1.

In vitro proliferation of GBM1A cells after increasing doses of VP treatment for (a) 24 and (b) 48 h. (c) GBM1A cells pretreated with VP (2.5 μM) for 24 h had higher radiosensitivity at increasing doses of radiation than corresponding vehicle-treated control cells. (d) The radiosensitivity was preserved at a prolonged 4 d time-point in JHGBM1A cells treated with VP and 10 Gray. All gray error bars are standard deviation. * = P < 0.05 as determined by ANOVA, Tukey’s multiple comparison test; compared to dose 0 μM.